Takeda acquires IDM Pharma - MarketLine Financial Deals

Takeda acquires IDM Pharma

Takeda acquires IDM Pharma - MarketLine Financial Deals
Takeda acquires IDM Pharma
Published Jun 24, 2009
3 pages — Published Jun 24, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Takeda America Holdings, Inc. (TAH) has acquired all of the outstanding shares of IDM Pharma, Inc., a biopharmaceutical company focused on the development of products that activate the immune system to treat cancer.

  
Source:
Document ID
MA04247_090519
Country
Country
Ticker
4502=JP
Ticker
IDMI=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Takeda acquires IDM Pharma" Jun 24, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Takeda-acquires-IDM-Pharma-2052-4068>
  
APA:
MarketLine Financial Deals. (2009). Takeda acquires IDM Pharma Jun 24, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Takeda-acquires-IDM-Pharma-2052-4068>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.